Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA damage by ionizing radiation refers to the molecular and cellular effects caused when high-energy radiation interacts with DNA molecules. Ionizing radiation includes X-rays, gamma rays, alpha and beta particles, and neutrons. It is capable of releasing electrons from atoms or molecules (ionization), which can break covalent bonds in biological macromolecules such as DNA. Types of damage include single-strand breaks (SSBs), double-strand breaks (DSBs), base damage, apurinic/apyrimidinic (AP) sites, DNA–protein crosslinks (DPCs), and clustered/complex lesions. If not properly repaired, these damages can result in cell death, mutagenesis leading to cancer development, or genomic instability. A key signature distinguishing ionizing-radiation-induced damage from endogenous chemical agents is damage clustering. Additionally, indirect effects via ROS generation contribute secondarily by producing diffusible damaging species affecting nearby genetic material.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA damage by ionizing radiation.